| Not Yet Recruiting | Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation NCT07072767 | State University of New York at Buffalo | N/A |
| Not Yet Recruiting | Antibiotics for Kidney Transplant Recipients NCT07106125 | University of California, San Francisco | Phase 4 |
| Not Yet Recruiting | (TNX-1500) in Kidney Transplant Recipients NCT07204080 | Ayman Al Jurdi, MD | Phase 2 |
| Recruiting | Kidney Protective Jacket NCT07348458 | iiShield | N/A |
| Recruiting | Personalized Stories for Pediatric Kidney Recipients NCT07532382 | Paris Translational Research Center for Organ Transplantation | — |
| Not Yet Recruiting | Older Kidney Patient Optimisation Pretransplant NCT07419945 | Guy's and St Thomas' NHS Foundation Trust | N/A |
| Not Yet Recruiting | Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney NCT07368153 | University Hospital, Basel, Switzerland | Phase 2 |
| Not Yet Recruiting | Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany NCT07348874 | University Hospital Heidelberg | — |
| Not Yet Recruiting | End-to-Side Interrupted Versus Continuous Arterial Suturing in Living Donor Kidney Transplantation NCT07274943 | Assiut University | — |
| Not Yet Recruiting | Pathways to Equitable Access to Kidney Transplantation in Spain: A Transformative Mixed-methods Study Protocol NCT07208994 | Hospital del Mar | — |
| Recruiting | A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function NCT07333495 | Tongji Hospital | — |
| Recruiting | A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population NCT07006831 | Devyser Inc. | — |
| Enrolling By Invitation | Worldwide Assessment of Deceased Donor Kidney Utilization NCT07341516 | Paris Translational Research Center for Organ Transplantation | — |
| Recruiting | Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Gener NCT07291258 | University Medical Center Groningen | — |
| Recruiting | Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis NCT07219121 | Travere Therapeutics, Inc. | Phase 4 |
| Not Yet Recruiting | POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS NCT07178964 | University Medical Centre Ljubljana | N/A |
| Not Yet Recruiting | "A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the Eur NCT07194057 | Instituto de Investigación Hospital Universitario La Paz | — |
| Recruiting | Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor NCT06919003 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Recruiting | Multimorbidity and Cardiovascular Risk Factors After Renal Transplant NCT07205692 | University Hospitals of Derby and Burton NHS Foundation Trust | — |
| Recruiting | Feasibility and Acceptability of a New Tool Promoting a Healthy Lifestyle in Liver and Kidney Transplant Recip NCT07305012 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Active Not Recruiting | TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation NCT07287800 | University of California, Los Angeles | Phase 1 / Phase 2 |
| Completed | Vouchers for Improving Transplant Access to Lifestyle Nutrition - Kidney Transplant NCT06953336 | University of California, San Francisco | N/A |
| Not Yet Recruiting | Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia NCT06988072 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients NCT06833463 | Chiesi Poland Sp. z o.o. | — |
| Recruiting | Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravuliz NCT06830798 | Alexion Pharmaceuticals, Inc. | Phase 3 |
| Recruiting | KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection NCT06830473 | University of Edinburgh | — |
| Recruiting | Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegal NCT07266467 | First Affiliated Hospital Xi'an Jiaotong University | Phase 4 |
| Recruiting | Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation NCT06288152 | Alp Sener | N/A |
| Not Yet Recruiting | Outcomes of a Pre-operative Exercise Programme for Live Donor and Recipient Kidney Transplant Patients NCT06858098 | University of Manchester | N/A |
| Recruiting | Predicting Outcomes in Posttransplant Diabetes Mellitus Via microRNA NCT07055984 | University Hospital, Martin | — |
| Withdrawn | Improving Access to Renal Transplantation for Underserved Black Communities NCT06707038 | Northwestern University | N/A |
| Recruiting | Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989 | Semmelweis University | — |
| Recruiting | An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Trans NCT06832410 | Vertex Pharmaceuticals Incorporated | Phase 3 |
| Completed | Erector Spınae Plane Block and Transmuscular Quadratus Lumborum Block In Kıdney Transplantatıon NCT07059455 | Kocaeli Derince Education and Research Hospital | N/A |
| Recruiting | Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation NCT06855758 | Beijing Friendship Hospital | N/A |
| Not Yet Recruiting | Preventing Delayed Graft Function in Kidney Transplant Patients NCT06724211 | University Health Network, Toronto | N/A |
| Not Yet Recruiting | Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant (PART) NCT06802822 | University of British Columbia | N/A |
| Not Yet Recruiting | Clinical Study on Thymus-Kidney Transplantation From Neonatal Donors for the Induction of Immune Tolerance NCT06715865 | RenJi Hospital | N/A |
| Recruiting | Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenari NCT06752577 | Mayo Clinic | — |
| Recruiting | Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL) NCT06640179 | University of Kansas Medical Center | N/A |
| Recruiting | MEMRI and Kidney Disease NCT06698614 | University of Edinburgh | — |
| Recruiting | Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection NCT06351488 | Assistance Publique - Hôpitaux de Paris | — |
| Recruiting | Social Support Counseling Intervention for Kidney Transplant Candidates NCT06147076 | Hennepin Healthcare Research Institute | N/A |
| Completed | Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized NCT06222554 | NYU Langone Health | N/A |
| Recruiting | Non-invasive Evaluation of Graft Condition in Adult Patients With Kidney Transplant Using Ultrasound Localizat NCT06472947 | University of Erlangen-Nürnberg Medical School | — |
| Recruiting | Advancing Transplantation Outcomes in Children NCT06055608 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Recruiting | CAR-T Cell Therapy for Desensitization in Kidney Transplantation NCT06056102 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Recruiting | Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant C NCT06809075 | Hospital Universitari Vall d'Hebron Research Institute | N/A |
| Recruiting | Empagliflozin Treatment in Kidney Transplant Recipients NCT06013865 | VA Office of Research and Development | Phase 4 |
| Completed | Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 Diabetes NCT07271433 | The Cleveland Clinic | — |
| Recruiting | Endovascular Preparation for Kidney Tranplantation NCT06677437 | Hospices Civils de Lyon | — |
| Recruiting | Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation NCT05917522 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients NCT06044493 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Recruiting | Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Reci NCT06025240 | Liverpool University Hospitals NHS Foundation Trust | — |
| Withdrawn | Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kid NCT05811468 | Rush University Medical Center | — |
| Recruiting | iParent2Parent Peer Support Program for Parents of Pediatric Kidney Transplant Recipients NCT05968833 | The Hospital for Sick Children | N/A |
| Unknown | Attitudes and Knowledge of Dialysis Patients Towards Kidney Transplantation NCT06148116 | Andrzej Frycz Modrzewski Krakow University | — |
| Active Not Recruiting | Immunogenicity of HPV Vaccine in Transplant Recipients. NCT05557370 | Medical College of Wisconsin | Phase 4 |
| Recruiting | Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation NCT06794970 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Alloreactive Memory B Lymphocytes and Anti-HLA Sensitization NCT07011238 | University Hospital, Rouen | — |
| Unknown | REmote moBile Outpatient mOnitoring in Transplant 2.0 NCT04721288 | University Health Network, Toronto | N/A |
| Recruiting | The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney NCT07222683 | Brigham and Women's Hospital | — |
| Unknown | Knowledge and Attitude of Dialysis Center Medical Staff Towards Living Kidney Donation NCT05797337 | Andrzej Frycz Modrzewski Krakow University | — |
| Completed | COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study NCT05518487 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Clinical Evaluation of the Nova Max Pro StatSensor Device NCT07392710 | Royal Free Hospital NHS Foundation Trust | N/A |
| Recruiting | Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre NCT06759961 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Recruiting | Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients NCT05456243 | Mayo Clinic | Phase 1 |
| Recruiting | TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation NCT06801262 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Completed | Home-based Therapeutic Drug Monitoring in Kidney Transplantation NCT05005221 | University of Michigan | N/A |
| Completed | Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients NCT05405556 | Martina McGrath, MD | Phase 2 |
| Recruiting | Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft NCT06794203 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | — |
| Withdrawn | KidneyCare Immuno-optimization in Renal Allografts (KIRA) NCT05423496 | CareDx | N/A |
| Active Not Recruiting | Pro-active Genetic Testing in Kidney Transplant Patients NCT05298904 | Mayo Clinic | — |
| Withdrawn | Exercise Intervention on Frailty After Kidney Transplantation NCT04275752 | Mayo Clinic | N/A |
| Completed | Impact of Double J Catheter in Major Urological Complications in Renal Transplant Recipients NCT07008131 | Instituto Mexicano del Seguro Social | N/A |
| Active Not Recruiting | Use of Predigraft in Kidney Transplant Patients NCT04969757 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients NCT05029310 | Oslo University Hospital | Phase 4 |
| Withdrawn | Evaluation of Interaction Between Immunosuppressive Drugs and Protein-bound Uremic Toxins in Renal Transplant NCT04963673 | Centre Hospitalier Universitaire, Amiens | — |
| Completed | Validation Study of the Feasibility of an Integrated Diagnostic System of Anatomo-pathological Lesions - Inclu NCT04581278 | Nantes University Hospital | — |
| Completed | Antibody After COVID-19 Vaccination NCT05057936 | Bangkok Metropolitan Administration Medical College and Vajira Hospital | — |
| Unknown | Transversus Abdominis Plane Catheter Following Kidney Transplantation NCT04786470 | Western University, Canada | Phase 3 |
| Completed | Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Com NCT04952766 | Centre Hospitalier Régional d'Orléans | Phase 4 |
| Completed | The Use of a Consumer-Based mHealth Dietary App and Health Coaching With Kidney Transplant Recipients NCT05151445 | Ohio State University | — |
| Recruiting | The KidneyCARE (Community Access to Research Equity) Study NCT05497518 | Tufts Medical Center | — |
| Unknown | Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2 NCT05125913 | Grigore T. Popa University of Medicine and Pharmacy | — |
| Completed | Pilot Social Support Counseling Intervention for Kidney Transplant Candidates NCT04363515 | Hennepin Healthcare Research Institute | N/A |
| Unknown | Effects of Dexmedetomidine on Microcirculation and Residual Kidney Function in Kidney Donors NCT04346290 | National Taiwan University Hospital | Phase 4 |
| Completed | SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans NCT04487197 | Antonio Secchi | — |
| Completed | Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patient NCT04377776 | IRCCS San Raffaele | — |
| Completed | A Pilot Study of mDOT for Immunosuppressant Adherence in Adolescent Kidney Transplant Recipients NCT03504137 | Johns Hopkins University | N/A |
| Active Not Recruiting | Microbiome and Immunosuppression: The Mission Study NCT04953715 | The University of Texas Medical Branch, Galveston | — |
| Completed | First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients NCT04431219 | Xenothera SAS | Phase 1 / Phase 2 |
| Recruiting | Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor NCT03707262 | Jeffrey Veale, MD | Phase 1 / Phase 2 |
| Completed | Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies NCT03837522 | St. Louis University | N/A |
| Completed | Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant NCT04087720 | Amgen | Phase 4 |
| Withdrawn | Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in S NCT03978494 | Sandoz | Phase 1 |
| Terminated | Effect of Moderate Caloric Restriction on Glomerular Growth After Kidney Transplantation NCT03607500 | University of Michigan | N/A |
| Completed | Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients NCT04023760 | University of Saskatchewan | Phase 4 |
| Terminated | NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation NCT03866421 | Rigshospitalet, Denmark | — |
| Active Not Recruiting | Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study NCT03726307 | Angus W. Thomson PhD DSc | Phase 1 |
| Completed | Utilization of Hepatitis C Positive Kidneys in Negative Recipients NCT03801707 | Ohio State University | Phase 2 / Phase 3 |
| Completed | A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients NCT03284242 | Roberto Gedaly | EARLY_Phase 1 |
| Completed | Reducing Disparities in Living Donor Transplant Among African Americans NCT03819686 | Emory University | N/A |
| Unknown | Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM) NCT04224350 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Completed | Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients NCT03713645 | Temple University | Phase 4 |
| Completed | Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Adva NCT03644485 | Astellas Pharma China, Inc. | Phase 4 |
| Completed | Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine NCT03527238 | University of Florida | Phase 2 |
| Completed | Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients NCT03749356 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Completed | The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipi NCT03558373 | Chiesi Farmaceutici S.p.A. | — |
| Terminated | Exercise to Treat Frailty and Decreased Physical Function in Transplant Candidates NCT03535584 | Mayo Clinic | N/A |
| Completed | A Randomized Controlled Trial of a Pre-Transplant Education Intervention NCT03633136 | University of Saskatchewan | N/A |
| Completed | Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial NCT03104868 | Northwestern University | N/A |
| Completed | Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft O NCT03794492 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Completed | Impact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney Transplantation NCT03423901 | University Hospital, Toulouse | N/A |
| Completed | PGDT in Patients Undergoing Kidney Transplant NCT05035537 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Completed | Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients. NCT04102943 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Completed | Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients NCT03249194 | Virginia Commonwealth University | EARLY_Phase 1 |
| Completed | Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemi NCT03229265 | The Rogosin Institute | Phase 4 |
| Completed | Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial NCT03045276 | Children's Hospital of Philadelphia | N/A |
| Withdrawn | Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant NCT02990312 | University of Maryland, Baltimore | Phase 4 |
| Terminated | Prospective Cohort of Kidney Transplanted Patients Receiving an Extended Releasing Tacrolimus-Everolimus Assoc NCT03228576 | Poitiers University Hospital | — |
| Terminated | Sargramostim for Myeloid Dendritic Cell Deficiency NCT03063242 | University of Florida | Phase 2 |
| Completed | Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant NCT02464878 | Massachusetts General Hospital | Phase 2 |
| Completed | Treg Therapy in Subclinical Inflammation in Kidney Transplantation NCT02711826 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Terminated | A Cohort Study of Operationally Tolerant Allograft Recipients NCT02743793 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Collaborative Care Intervention for Chronic Kidney Disease NCT02938351 | University of Pittsburgh | N/A |
| Completed | Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant NCT02429869 | University of California, San Francisco | Phase 4 |
| Active Not Recruiting | Preparing for Kidney Transplant by Attaining a Healthy Weight NCT02986243 | University of Chicago | N/A |
| Completed | Effects of Inhibiting Early Inflammation in Kidney Transplant Patients NCT02495077 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | The Effect of Neuromuscular Stimulation on Post-Transplant Leg Edema NCT01860820 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | Effects of Personalized Physical Rehabilitation in Kidney Transplant Recipients NCT02409901 | University of Illinois at Chicago | N/A |
| Completed | Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children NCT02182986 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Unknown | Impact of CYP3A5 Gene Polymorphisms on Tacrolimus Concentrations and Outcomes in Thai Transplant Recipients NCT02377791 | Mahidol University | — |
| Completed | A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney NCT02057484 | Astellas Pharma Europe Ltd. | — |
| Completed | Transplant Navigator Dissemination NCT01981603 | Catherine Sullivan | N/A |
| Completed | A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was NCT02034747 | Astellas Pharma Korea, Inc. | Phase 4 |
| Completed | Transversus Abdominis Plane Block During Kidney Transplant Surgery NCT02080728 | Centre Hospitalier Universitaire Dijon | Phase 4 |
| Unknown | Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function NCT01837043 | Nair, Vinay, D.O. | Phase 2 |
| Completed | Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients NCT01791491 | Bristol-Myers Squibb | Phase 2 |
| Completed | Prospective Single-center Study Evaluating the Central Blood Pressure in Renal Transplantation NCT02528591 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | A Prospective, Open Label Study of CERtican in KIdney Transplantation NCT01594268 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population NCT01914354 | The Cleveland Clinic | — |
| Unknown | Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transp NCT01455649 | Deise de Boni Monteiro de Carvalho | Phase 4 |
| Unknown | Prospective Donor Specific Antibody (DSA) Monitoring Protocol NCT01382355 | Providence Health & Services | — |
| Completed | Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients NCT01289717 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Enhancing Education Regarding Living Donor Transplant Among Kidney Transplant Candidates NCT01261910 | St. Barnabas Medical Center | N/A |
| Completed | ACtive Care After Transplantation, the ACT Study NCT01047410 | University Medical Center Groningen | N/A |
| Completed | ABO- or HLA- Incompatible LDKT Compared to Waitlist/DDKT in Elderly Patients NCT07436338 | Seoul National University Hospital | — |
| Terminated | Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosu NCT01166724 | The Cleveland Clinic | Phase 3 |
| Completed | Long-term Follow-up of Spare the Nephron (STN) Patients NCT01126333 | University of Maryland, Baltimore | — |
| Terminated | Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transpla NCT01095887 | Mayo Clinic | Phase 1 / Phase 2 |
| Terminated | Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Tran NCT01106027 | Mayo Clinic | Phase 1 / Phase 2 |
| Completed | Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil W NCT01025817 | Novartis Pharmaceuticals | Phase 3 |
| Suspended | Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients NCT01021943 | Instituto Nacional de Cardiologia Ignacio Chavez | Phase 2 |
| Completed | Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation NCT00940940 | University of Alberta | Phase 4 |
| Completed | Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients NCT00895583 | Pfizer | Phase 4 |
| Terminated | Tacrolimus to Sirolimus Conversion for Delayed Graft Function NCT00931255 | University of Maryland, Baltimore | Phase 4 |
| Completed | Intensive Insulin Therapy in Deceased Donors NCT01140035 | University of California, San Francisco | N/A |
| Terminated | Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipie NCT00663455 | University of Erlangen-Nürnberg Medical School | Phase 4 |
| Terminated | Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance NCT00752479 | Mario Negri Institute for Pharmacological Research | Phase 1 / Phase 2 |
| Unknown | Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy NCT00659620 | Fuzhou General Hospital | Phase 1 / Phase 2 |
| Completed | Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Trans NCT00670774 | Mark Stegall | Phase 1 / Phase 2 |
| Completed | Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients NCT01802268 | Helio Tedesco Silva Junior | Phase 4 |
| Completed | Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To NCT00502242 | Pfizer | Phase 4 |
| Completed | Cell-mediated Immune Response to Influenza Vaccine NCT00677547 | University of Alberta | — |
| Completed | Melatonin and Adiponectin in Hypertensive Kidney Transplant NCT00498576 | Sheba Medical Center | — |
| Withdrawn | Observational Registry Study of Renal Transplant Patients NCT01284257 | Novartis Pharmaceuticals | — |
| Completed | MMF vs. AZA for Kidney Transplantation NCT00494741 | Mario Negri Institute for Pharmacological Research | Phase 4 |
| Completed | Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant NCT00466518 | University of Oklahoma | N/A |
| Unknown | EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function NCT00302497 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 3 |
| Terminated | Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients NCT00433953 | Children's Hospital Medical Center, Cincinnati | Phase 1 |
| Completed | Protective Immunity Project 02 NCT00833651 | Emory University | — |
| Unknown | Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to NCT00676221 | Foothills Medical Centre | Phase 4 |
| Completed | Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regi NCT00537862 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies NCT00307125 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Terminated | WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commerc NCT00275314 | University of Pittsburgh | Phase 3 |
| Terminated | Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab NCT01213329 | Northwestern University | Phase 4 |
| Completed | PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients NCT00281619 | Children's Hospital Medical Center, Cincinnati | — |
| Completed | The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients. NCT00275522 | Mayo Clinic | Phase 4 |
| Completed | A Study of Factors That Affect Long-Term Kidney Transplant Function NCT00270712 | University of Minnesota | — |
| Completed | The Study of Long-term Deterioration of Kidney Transplants. NCT00217126 | Mayo Clinic | — |
| Completed | Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation NCT00642655 | Cedars-Sinai Medical Center | Phase 1 / Phase 2 |
| Completed | Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM) NCT00296296 | Stanford University | Phase 4 |
| Terminated | Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant NCT00137345 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant NCT00309309 | Mario Negri Institute for Pharmacological Research | Phase 2 |
| Completed | A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipien NCT00275717 | Mayo Clinic | — |
| Completed | The Paired Donation Consortium Paired Donation Program NCT00374400 | University of Cincinnati | — |
| Completed | Organ Preservation Media Investigation NCT00225472 | University of Wisconsin, Madison | Phase 1 |
| Completed | Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants NCT00257387 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 1 / Phase 2 |
| Completed | Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant R NCT00266123 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation NCT00141037 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney T NCT00171496 | Novartis | Phase 4 |
| Completed | A Study Of CP-690,550 In Stable Kidney Transplant Patients NCT01710033 | Pfizer | Phase 1 |
| Completed | Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transpl NCT00309270 | Mario Negri Institute for Pharmacological Research | Phase 2 |
| Completed | Prediction of Acute Rejection in Renal Transplant NCT00205257 | University of Wisconsin, Madison | — |
| Completed | Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Pa NCT00223678 | Vanderbilt University Medical Center | Phase 4 |
| Completed | Natural History Study of Azathioprine Adherence NCT00143910 | Thomas E. Nivens, MD | — |